key: cord-0721177-6ntvbee3
authors: Xu, R.; Zhou, Y.; Cai, L.; Wang, L.; Han, J.; Yang, X.; Chen, J.; Chen, J.; Ma, C.; Shen, L.
title: Co‐Reactivation of Human Herpesvirus alpha Subfamily (HSV Ⅰ and VZV) in Critically Ill Patient with COVID‐19
date: 2020-08-13
journal: Br J Dermatol
DOI: 10.1111/bjd.19484
sha: c88dca354a357320ed7af92df1520d0f7328b55e
doc_id: 721177
cord_uid: 6ntvbee3

Coronavirus disease 2019 (COVID‐19) is already well known globally(1). The Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2 infection) causes a spectrum of severe clinical manifestations, which leads to a high rate of intensive care unit (ICU) admissions and mortality. We report a first case of COVID‐19 with reactivation of human herpesvirus (HHV) alpha subfamily (herpes simplex virus I [HSV Ⅰ] and varicella‐zoster virus [VZV]). Due to the immunosuppressive state associated with COVID‐19, infection of the HHV alpha subfamily (HSV Ⅰ and VZV) could be potentially life threatening.

This article is protected by copyright. All rights reserved Coronavirus disease 2019 (COVID-19) is already well known globally 1 . The Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 infection) causes a spectrum of severe clinical manifestations, which leads to a high rate of intensive care unit (ICU) admissions and mortality. We report a first case of COVID-19 with reactivation of human herpesvirus (HHV) alpha subfamily (herpes simplex virus I [HSV Ⅰ] and varicella-zoster virus [VZV] ). Due to the immunosuppressive state associated with COVID-19, infection of the HHV alpha subfamily (HSV Ⅰ and VZV) could be potentially life threatening.

A 73-year-old man, with respiratory symptoms and positive nucleic acid test of throat swab specimens, was diagnosed with SARS-CoV-2 infection on 2 February. As the respiratory symptoms deteriorated, he was admitted to ICU.

Due to the rapid aggravation of respiratory distress, onset of septic shock, and progression of chest imaging, the application of veno-venous extracorporeal membrane oxygenation (VV-ECMO) for respiratory support was performed on 15th February. After comprehensive treatment and assisted ventilation, the oxygenation index and relevant indicators improved. The patient's clinical condition stabilised with downtrending SARS-CoV-2 viral load and improvement in his sepsis biomarkers For continuous monitoring of the infection status, serial follow-up pathogen Next Generation Sequence (NGS) tests were performed ( Figure 1A ), including tests on blood, sputum and bronchoalveolar lavage fluid (BALF). On 8th March, the patient suffered from a second septic shock. The blood pathogen NGS report (8th March) revealed the onset of VZV and HSV Ⅰ reactivation. Two days after, multiple clusters of haemorrhagic blisters, bullae and diffuse erosions covered right lateral arm, shoulder, and neck of the patient ( Figure 1B) . Meanwhile, liver function showed the second highest peak during the treatment course.

The report from BALF also showed a higher sequence number of HSV Ⅰ on 8th March. Accordingly, his chest radiograph suddenly worsened with a left pneumothorax. In addition, we found several small ulcers on bronchial mucosa during fibreoptic

This article is protected by copyright. All rights reserved bronchoscopy, as shown in Figure 1C . After antiviral treatment (acyclovir 0.5g Ivdrip. q8h), all parameters gradually improved.

HSV Ⅰ and VZV are DNA viruses belonging to neurotropic alpha herpesvirus subfamily 2 . After primary infection, they both can formulate a latent infection. However, once the interactional balance between the host immunity and the virus is broken, following battle in the immune system might be complicated and fierce, involving multiple organs (cutaneous, liver, kidney and brain) 3 .

In our case, the onset of viraemia (VZV and HSV Ⅰ) might have triggered the second septic shock. During fibreoptic bronchoscopy, we found several small ulcers on the mucosal membrane of bronchi ( Figure 1C) , and the reports of BAFL and blood tests illustrated the onset of VZV and HSV Ⅰ reactivation. Meanwhile, the serial Chest radiographs suddenly aggravated. Besides the manifestation in lung and skin, the second highest peak of liver dysfunction might be related to the reactivation of HHV alpha subfamily.

The Immunological characteristics of COVID-19 patients are variable. They suffer from a cytokine storm syndrome and immunosuppression, especially for a subgroup of critically ill patients 4 , which suggests an unbalanced immune response and exhaustion of multiple cytokines; this could be one of the reasons for the HSV Ⅰ/VZV reactivation. The SARS-CoV-2 infection affects T lymphocytes, particularly CD4+T cells, CD8+ T cells 4 and natural killer (NK) cells 5 , resulting in functional exhaustion and decreases in numbers. The resulting immunosuppressive state may encourage reactivation of latent viral infection, resulting in sudden worsening of symptoms in the course of recovery.

Until now, most reports of COVID-19 inpatients have characterised the data without including screening tests for other viral infections. In this case, we identified a viraemia (HSV I and VZV) that resulted in an aggravated disease course. Simultaneous infection with VZV and HSV Ⅰ has rarely been reported. The clinical presentation of coreactivation could be skin manifestations, localised in the same or different dermatomal areas 6 , or due to their different anatomical latent sites, they could be separately or simultaneously detected in isolated organs, Severe and lethal cases are prone to occur in older immunocompromised patients 7 .

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan

T-cell immunity to human alphaherpesviruses

Herpes simplex virus-1 and varicella-zoster virus latency in ganglia

Clinical and immunologic features in severe and moderate Coronavirus Disease

Functional exhaustion of antiviral lymphocytes in COVID-19 patients

Identification and characterization of 20 immunocompetent patients with simultaneous varicella zoster and herpes simplex virus infection

Disseminated herpes simplex virus and varicella zoster virus coinfection in a patient taking thalidomide for relapsed multiple myeloma

This article is protected by copyright. All rights reservedIn conclusion, co-reactivation of latent viruses could aggravate the COVID-19 disease course. Viral-related screening and detection tests should take cognizance of the following points: 1. Although improvements in chest imaging or decreases in SARS-CoV-2 RNA load or IgG & IgM, respiratory symptoms and chest image suddenly worsened along with symptoms related to other organ system injuries (unexplainable liver or kidney injury).Thus, in addition to suspicion of secondary bacterial infection, viral infection should also be considered. 2. If scattered vesicles or ulcers are found during the fibreoptic bronchoscopy, HSV Ⅰ/VZV-related pulmonary infection should be suspected.